A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/05/2011	EP2252611B1 (dihydro)pyrrolo[2,1-a]isoquinolines
10/05/2011	EP2240492B1 Process for the preparation of asenapine and intermediate products used in said process
10/05/2011	EP2173744B1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
10/05/2011	EP2150553B1 Condensed heterocyclic compounds as inhibitors of protein kinases
10/05/2011	EP2144506B1 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
10/05/2011	EP2129377B1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
10/05/2011	EP2123271B1 Drug for treatment of influenza
10/05/2011	EP2117534B1 A pharmaceutical composition with atorvastatin active ingredient
10/05/2011	EP2102186B1 Indoles
10/05/2011	EP2083920B1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use
10/05/2011	EP2049090B1 Use of 5-ht7 receptor agonists for the treatment of pain
10/05/2011	EP2040724B1 Biotherapeutic compositions comprising probiotic escherichia coli and metronidazole and uses thereof
10/05/2011	EP2018388B9 Bisadenosine compounds as adenosine a2a receptor agonists
10/05/2011	EP1994029B1 Potassium channel inhibitors
10/05/2011	EP1989207B1 Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
10/05/2011	EP1986651B1 Use of a pyrimidinedione derivative for preventing or treating hepatitis c
10/05/2011	EP1968963B1 Substituted propiolic acid amides and their use for producing analgesics
10/05/2011	EP1966151B1 Polycyclic indazole derivatives that are erk inhibitors
10/05/2011	EP1960370B1 Pyridiazinone derivatives for tumour treatment
10/05/2011	EP1948245B1 Compositions and their uses for gene therapy of bone conditions
10/05/2011	EP1931806B1 Pkr activation via hybridization chain reaction
10/05/2011	EP1920370B1 Magnetic drug, magnetic drug guidance system and magnetic drug design method
10/05/2011	EP1899352B1 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors
10/05/2011	EP1899329B1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
10/05/2011	EP1890994B1 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
10/05/2011	EP1888558B1 Bicyclic derivatives as modulators of ion channels
10/05/2011	EP1874311B1 A method for preventing, delaying or reverting abnormal amyloid deposition
10/05/2011	EP1858520B1 Quinazolinone t-type calcium channel antagonists
10/05/2011	EP1828389B1 Sparc promoter mutations associated with drug resistance, and methods associated therewith
10/05/2011	EP1825856B1 Oral composition containing difructose anhydride
10/05/2011	EP1812002B1 Treatment of mastitis
10/05/2011	EP1787991B1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
10/05/2011	EP1778234B1 Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
10/05/2011	EP1731042B1 Feed additive for laying hens and feed containing the additive
10/05/2011	EP1708717B1 Atomoxetine for treatment of allergic rhinitis and asthma
10/05/2011	EP1706415B1 Lipid- derivatized bisphosphonic acid
10/05/2011	EP1680144B1 Methylphenidate solution and associated methods of administration and production
10/05/2011	EP1664327B1 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS
10/05/2011	EP1660682B1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/05/2011	EP1656139B1 Aryl dicarboxamides
10/05/2011	EP1651224B1 Medicaments for inhalation comprising an anticholinergic and a betamimetic
10/05/2011	EP1648874B1 Piperazine derivatives and their use as therapeutic agents
10/05/2011	EP1575940B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/05/2011	EP1567490B1 Anti-sickling agents
10/05/2011	EP1562577B1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by thalidomide
10/05/2011	EP1546136B1 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them
10/05/2011	EP1501830B1 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
10/05/2011	EP1463497B1 Treating muscle wasting with selective androgen receptor modulators
10/05/2011	EP1454903B9 Thiadiazoline derivatives for treating cancer
10/05/2011	EP1411052B1 Benzo-fused 5-membered hetrocycle compounds,process for preparation of the same, and use thereof
10/05/2011	EP1406633B1 Enhanced drug delivery in transdermal systems
10/05/2011	EP1395279B1 Use of neublastin polypeptides for treating neuropathic pain
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	EP1372389B1 Virucidal compositions
10/05/2011	EP1317262B1 Topically applied hoof treatment composition concentrate
10/05/2011	EP1295607B9 Antitumor effect potentiators
10/05/2011	EP1278758B1 Combretastatin A-1 phosphate and Combretastatin B-1 phosphate prodrugs
10/05/2011	EP1267945B1 Genetically modified cells expressing a tgf-beta inhibitor, the cells being lung cancer cells
10/05/2011	EP1257248B1 Pharmaceutical composition
10/05/2011	EP1230209B3 Stable salts of novel derivatives of 3,3-diphenylpropylamines
10/05/2011	EP1179984B2 Process for manufacturing a product for enhancing immune response in companion animal using a combination of antioxidants
10/05/2011	EP1069883B1 Self-tanning compositions comprising cholesterol sulphate and DHA
10/05/2011	EP1017835B1 Cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy
10/05/2011	CN201996869U Enteric particle of enrofloxacin
10/05/2011	CN201996868U Slow release gelatin microsphere
10/05/2011	CN1990006B Chenopodium ambrosioides extract, preparation thereof, preparation method and use thereof
10/05/2011	CN1985847B Use of low molecular weight brown algae polyose fulfate in preparing medicine for treating cardiac and cerebral vascular diseases
10/05/2011	CN1946407B Methods and composition for treating tumors and metastatic disease
10/05/2011	CN1946372B Use of heat shock protein inhibitors for the reduction of hair growth
10/05/2011	CN1938285B 4-anilinequinazolines with adenosine-kiase inhibitor properties
10/05/2011	CN1919238B Medicine for treating cardiovascular and cerebrovascular disease
10/05/2011	CN1919237B Medicine for treating cardiovascular and cerebrovascular diseases
10/05/2011	CN1896069B Substituted-thiazole-4-ketone, its preparation and use
10/05/2011	CN1894231B Furan derivatives as ep4 receptor antagonists
10/05/2011	CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity
10/05/2011	CN1817883B New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
10/05/2011	CN1806796B Pharmaceutical composition containing valibose, its preparation method and application
10/05/2011	CN1732934B Freeze dry betahistine hydrochloride injection and method for preparing the same
10/05/2011	CN1617704B Composition comprising at least one oxazolin for inhibiting langerhans cell migration, and uses thereof
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use
10/05/2011	CN102209784A Periostin-induced pancreatic regeneration
10/05/2011	CN102209781A Isolation and identification of glycosaminoglycans
10/05/2011	CN102209731A A heparan sulphate which binds bmp2
10/05/2011	CN102209721A Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
10/05/2011	CN102209719A Novel prostaglandin i2 derivative
10/05/2011	CN102209718A Carbamate compound or salt thereof
10/05/2011	CN102209717A Compounds for the treatment of hepatitis c
10/05/2011	CN102209716A Novel compounds as cannabinoid receptor ligands
10/05/2011	CN102209713A 1- (arylsulfonyl) -4- (pi perazin-i -yl) -ih-benz imidazoles as d-hydroxytryptamine- 6 ligands
10/05/2011	CN102209711A Compounds for the treatment of hepatitis c
10/05/2011	CN102209710A Pyrrolidines
10/05/2011	CN102209705A Crystalline forms of fingolimod hcl
10/05/2011	CN102209551A Composition for inhibiting fgf-5, hair tonic, and composition for external use on livestock
10/05/2011	CN102209548A Compositions comprising polymers having amino sugar units and methods of making and using same
10/05/2011	CN102209547A Protein phosphatase inhibitor
10/05/2011	CN102209546A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
10/05/2011	CN102209545A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
10/05/2011	CN102209544A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
10/05/2011	CN102209543A Pirfenidone treatment for patients with atypical liver function
10/05/2011	CN102209542A Octenidine composition

1 ... 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 ... 7860